67 related articles for article (PubMed ID: 35626300)
1. Portal vein thrombosis with contrast-enhanced ultrasound in a patient with hepatocellular carcinoma: a case study.
Salman S
Australas J Ultrasound Med; 2012 May; 15(2):67-70. PubMed ID: 28191145
[TBL] [Abstract][Full Text] [Related]
2. Transplant and non-transplant HCC patients at a single institution.
Carr BI; Bag H; Ince V; Isik B; Baskiran A; Yilmaz S
Hepatol Forum; 2024; 5(2):77-86. PubMed ID: 38487742
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 4D Flow MRI-Derived Relative Residence Time as a Marker for Cirrhosis Associated Portal Vein Thrombosis.
Hyodo R; Takehara Y; Ishizu Y; Nishida K; Mizuno T; Ichikawa K; Horiguchi R; Kurata N; Ogura Y; Yokoyama S; Naganawa S; Jin N; Ichiba Y
J Magn Reson Imaging; 2024 Mar; ():. PubMed ID: 38490816
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood platelet counts identify prognostically diverse clinical phenotypes in hepatocellular carcinoma.
Carr BI; Bag HG; Yilmaz S
Ann Gastroenterol Dig Syst; 2024; 7(1):. PubMed ID: 38887309
[TBL] [Abstract][Full Text] [Related]
5. The Role of Contrast-Enhanced Ultrasound (CEUS) in the Detection of Neoplastic Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma.
Cerrito L; Ainora ME; Di Francesco S; Galasso L; Gasbarrini A; Zocco MA
Tomography; 2023 Oct; 9(5):1976-1986. PubMed ID: 37888746
[TBL] [Abstract][Full Text] [Related]
6. Portal vein thrombosis in liver cirrhosis - the added value of contrast enhanced ultrasonography.
Danila M; Sporea I; Popescu A; Șirli R
Med Ultrason; 2016 Jun; 18(2):218-33. PubMed ID: 27239658
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of Imaging and Biological Tools for the Characterization of Portal Vein Thrombosis in Hepatocellular Carcinoma.
Burciu C; Șirli R; Bende F; Fofiu R; Popescu A; Sporea I; Ghiuchici AM; Miuțescu B; Dănilă M
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626300
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis.
Chen J; Zhu J; Zhang C; Song Y; Huang P
Eur Radiol; 2020 May; 30(5):2871-2880. PubMed ID: 32020403
[TBL] [Abstract][Full Text] [Related]
9. Role of contrast-enhanced ultrasound for differentiation of benign vs. malignant portal vein thrombosis in hepatocellular carcinoma - A systematic review a meta-analysis.
Giri S; Vaidya A; Agrawal D; Varghese J; Patel RK; Tripathy T; Singh A; Das S
Australas J Ultrasound Med; 2024 Feb; 27(1):56-64. PubMed ID: 38434544
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma.
Tarantino L; Ambrosino P; Di Minno MN
World J Gastroenterol; 2015 Aug; 21(32):9457-60. PubMed ID: 26327753
[TBL] [Abstract][Full Text] [Related]
11. B-mode and contrast enhanced ultrasound guided biopsy of portal vein thrombosis. Value in the diagnosis of occult hepatocellular carcinoma in liver cirrhosis.
Sparchez Z; Radu P; Zaharia T; Kacso G; Diaconu B; Grigorescu I; Badea R
Med Ultrason; 2010 Dec; 12(4):286-94. PubMed ID: 21210013
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US: a pilot study.
Song ZZ; Huang M; Jiang TA; Zhao QY; Yao L; Mou Y; Zhao JK; Ao JY; Chen F; Chen Y
Eur J Radiol; 2010 Aug; 75(2):185-8. PubMed ID: 19464131
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
